Patient views on paliperidone palmitate 3-monthly: a cross-sectional questionnaire in UK community mental health teams
Therapeutic Advances in Psychopharmacology
Published online on May 19, 2026
Abstract
Therapeutic Advances in Psychopharmacology, Volume 16, XX 2026.
Background:Naturalistic studies examining paliperidone palmitate 3-monthly (PP3M) long-acting injection have proven PP3M to be a safe and effective maintenance treatment for patients with schizophrenia.Objectives:The aim of this study is to explore ...
Background:Naturalistic studies examining paliperidone palmitate 3-monthly (PP3M) long-acting injection have proven PP3M to be a safe and effective maintenance treatment for patients with schizophrenia.Objectives:The aim of this study is to explore ...